News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

SynteractHCR Addressing Successful Ways to Approach Sponsor and CRO Collaboration at May Pharmaceutical Events in U.S. and Europe


5/3/2013 8:57:47 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SAN DIEGO, May 2, 2013 /PRNewswire/ -- SynteractHCR, a full-service, global contract research organization (CRO), will attend and present at two conferences in May, Outsourcing in Clinical Trials Southeast and Outsourcing in Clinical Trials Europe. Speakers Barbara Ruby and Dr. Sonja Weiser will address the relationship between sponsors and outsourced clinical research organizations and how their collaboration aids in the success of trials.

(Logo: http://photos.prnewswire.com/prnh/20111108/MM02925LOGO)

Outsourcing in Clinical Trials Southeast will take place in Raleigh-Durham, NC from May 7-8, 2013. SynteractHCR will exhibit at booth #22. Barbara Ruby, associate project director, will present "CRO/Sponsor Successful Collaboration: How to Effectively Work Together" at 2:00 p.m. EDT on May 7th. Ms. Ruby has more than 20 years of experience in clinical research including multiple roles as a study coordinator, sub-investigator, monitor and project manager at both CROs and biotech companies. Her presentation will include how to establish a clinical trial agreement that is clear and comprehensive, how to create team transparency from the outset, and how to manage the unexpected and establish accountability.

The third annual Outsourcing in Clinical Trials Europe will take place in Zurich, Switzerland from May 14-15, 2013. SynteractHCR will exhibit at booth #33. Dr. Sonja Weiser,Regional Director, Nordic & East, will present "Applying Result-driven Techniques to Successfully Transition (and Save) a Failing Study" at 4:00 p.m. CET on May 14th. The presentation will include how to determine when a service provider is not performing and identify when a change in service provider is needed, how to select a new CRO, and how to facilitate a smooth transition that keeps the study on track. Dr. Weiser has more than 13 years of experience in the field of clinical research in pharma and biotech, as well as six years experience in an international CRO environment.

In March, 2013 SynteractHCR was formed from the merger of Synteract and Harrison Clinical Research (HCR), and operates from 16 locations worldwide to support large, later phase programs. To set up an appointment, contact Matt Smith, SVP sales and marketing at (760) 268-8200.

About SynteractHCR (www.synteracthcr.com)

SynteractHCR is a full-service contract research organization with a successful two-decade track record supporting biotechnology, medical device and pharmaceutical companies in all phases of clinical development. With its "Shared Work Shared Vision" philosophy SynteractHCR provides customized Phase I through IV services collaboratively and cost effectively ensuring on-time delivery of quality data so clients get to decision points faster. Operating in 16 countries, SynteractHCR delivers trials internationally, offering expertise across multiple therapeutic areas including notable depth in oncology, CNS, infectious disease, endocrinology, cardiovascular and respiratory, among other indications.

CONTACT:
Rachel Hutman
Rachel@clearpointagency.com
760-230-2424

SOURCE SynteractHCR



Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES